Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study

MLA

Masoud Etemadifar, et al. “Does COVID-19 Increase the Long-Term Relapsing-Remitting Multiple Sclerosis Clinical Activity? A Cohort Study.” BMC Neurology, vol. 22, no. 1, Feb. 2022, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s12883-022-02590-9.

APA

Masoud Etemadifar, Amir Parsa Abhari, Hosein Nouri, Mehri Salari, Shiva Maleki, Alireza Amin, & Nahad Sedaghat. (2022). Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study. BMC Neurology, 22(1), 1–7. https://doi.org/10.1186/s12883-022-02590-9

Chicago

Masoud Etemadifar, Amir Parsa Abhari, Hosein Nouri, Mehri Salari, Shiva Maleki, Alireza Amin, and Nahad Sedaghat. 2022. “Does COVID-19 Increase the Long-Term Relapsing-Remitting Multiple Sclerosis Clinical Activity? A Cohort Study.” BMC Neurology 22 (1): 1–7. doi:10.1186/s12883-022-02590-9.